Home Cart 0 Sign in  

[ CAS No. 174855-57-3 ]

{[proInfo.proName]} ,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 174855-57-3
Chemical Structure| 174855-57-3
Structure of 174855-57-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Bulk Inquiry Add To Cart

Quality Control of [ 174855-57-3 ]

Related Doc. of [ 174855-57-3 ]

Alternatived Products of [ 174855-57-3 ]

Product Details of [ 174855-57-3 ]

CAS No. :174855-57-3 MDL No. :MFCD05864664
Formula : C16H22N2O3 Boiling Point : -
Linear Structure Formula :- InChI Key :FGJACYJASSSXNJ-UHFFFAOYSA-N
M.W :290.36 g/mol Pubchem ID :6490990
Synonyms :

Calculated chemistry of [ 174855-57-3 ]

Physicochemical Properties

Num. heavy atoms : 21
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 5
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 89.03
TPSA : 49.85 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.98
Log Po/w (XLOGP3) : 2.17
Log Po/w (WLOGP) : 1.79
Log Po/w (MLOGP) : 1.53
Log Po/w (SILICOS-IT) : 1.88
Consensus Log Po/w : 2.07

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.89
Solubility : 0.375 mg/ml ; 0.00129 mol/l
Class : Soluble
Log S (Ali) : -2.85
Solubility : 0.41 mg/ml ; 0.00141 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.02
Solubility : 0.277 mg/ml ; 0.000953 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 2.31

Safety of [ 174855-57-3 ]

Signal Word:Warning Class:
Precautionary Statements:P280-P305+P351+P338 UN#:
Hazard Statements:H317-H319 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 174855-57-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 174855-57-3 ]
  • Downstream synthetic route of [ 174855-57-3 ]

[ 174855-57-3 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 446-52-6 ]
  • [ 57260-71-6 ]
  • [ 174855-57-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2003, vol. 13, # 21, p. 3793 - 3796
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 17, p. 4417 - 4423
[3] Journal of Medicinal Chemistry, 2004, vol. 47, # 27, p. 6821 - 6830
[4] Journal of Organic Chemistry, 2005, vol. 70, # 22, p. 8924 - 8931
[5] Synthesis, 2010, # 24, p. 4287 - 4299
[6] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5605 - 5609
[7] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 17, p. 4817 - 4822
[8] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 14, p. 4599 - 4604
  • 2
  • [ 111373-03-6 ]
  • [ 174855-57-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 3, p. 744 - 755
  • 3
  • [ 24424-99-5 ]
  • [ 736991-52-9 ]
  • [ 174855-57-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2004, vol. 47, # 3, p. 744 - 755
  • 4
  • [ 24424-99-5 ]
  • [ 174855-57-3 ]
Reference: [1] Patent: WO2006/133098, 2006, A2, . Location in patent: Page/Page column 3/18
  • 5
  • [ 174855-57-3 ]
  • [ 736991-52-9 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 17, p. 4417 - 4423
[2] Bioorganic and Medicinal Chemistry Letters, 2004, vol. 14, # 22, p. 5605 - 5609
[3] Journal of Medicinal Chemistry, 2004, vol. 47, # 27, p. 6821 - 6830
[4] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 20, p. 4615 - 4618
  • 6
  • [ 174855-57-3 ]
  • [ 444582-90-5 ]
YieldReaction ConditionsOperation in experiment
95%
Stage #1: With aminosulfonic acid In 1,4-dioxane; water at 4℃; for 0.5 h;
Stage #2: With sodium chlorite In 1,4-dioxane; water
An alternative method for preparing this intermediate is as follows. 4-(2-Formyl- phenyl)-piperazine-l-carboxylic acid tert-buty\\ ester (0.50 g, 1.72 mmol) is dissolved in 80 mL of dioxane and 20 mL of H2O. The mixture is cooled to 4° C. To this is added sulfamic acid (1.36 g, 14.00 mmol) in one portion. The mixture is stirred for an additional 30 min. To this is added 3 mL of a solution of NaClO2 (0.343 g, 3.80 mmol) in a dropwise manner. The reaction is quenched reaction with addition of 50 mL of H2O and 50 mL of brine. The mixture is extracted with 3x100 mL of CH2Cl2. The organic phase is washed with 2x50 niL of brine, dried (MgSO4), filtered and concentrated to give 500 mg of 4-(2-carboxy-phenyl)-piperazine-l-carboxylic acid tert-butyl ester, 95 percent yield.
Reference: [1] Patent: WO2010/126851, 2010, A1, . Location in patent: Page/Page column 77-78
[2] Patent: WO2010/126811, 2010, A1, . Location in patent: Page/Page column 144-145
Historical Records

Related Functional Groups of
[ 174855-57-3 ]

Aryls

Chemical Structure| 197638-83-8

[ 197638-83-8 ]

1-Boc-4-(4-Formylphenyl)piperazine

Similarity: 0.93

Chemical Structure| 1257849-25-4

[ 1257849-25-4 ]

1-Boc-4-(3-Formylphenyl)piperazine

Similarity: 0.92

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.88

Chemical Structure| 927676-52-6

[ 927676-52-6 ]

tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate

Similarity: 0.88

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.86

Aldehydes

Chemical Structure| 197638-83-8

[ 197638-83-8 ]

1-Boc-4-(4-Formylphenyl)piperazine

Similarity: 0.93

Chemical Structure| 1257849-25-4

[ 1257849-25-4 ]

1-Boc-4-(3-Formylphenyl)piperazine

Similarity: 0.92

Chemical Structure| 391668-75-0

[ 391668-75-0 ]

tert-Butyl 6-formylindoline-1-carboxylate

Similarity: 0.84

Chemical Structure| 343306-50-3

[ 343306-50-3 ]

tert-Butyl 4-(3-formyl-4-hydroxyphenyl)piperazine-1-carboxylate

Similarity: 0.83

Chemical Structure| 1446332-69-9

[ 1446332-69-9 ]

tert-Butyl 4-(4-formyl-3-hydroxyphenyl)piperazine-1-carboxylate

Similarity: 0.82

Amides

Chemical Structure| 197638-83-8

[ 197638-83-8 ]

1-Boc-4-(4-Formylphenyl)piperazine

Similarity: 0.93

Chemical Structure| 1257849-25-4

[ 1257849-25-4 ]

1-Boc-4-(3-Formylphenyl)piperazine

Similarity: 0.92

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.88

Chemical Structure| 927676-52-6

[ 927676-52-6 ]

tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate

Similarity: 0.88

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.86

Related Parent Nucleus of
[ 174855-57-3 ]

Piperazines

Chemical Structure| 197638-83-8

[ 197638-83-8 ]

1-Boc-4-(4-Formylphenyl)piperazine

Similarity: 0.93

Chemical Structure| 1257849-25-4

[ 1257849-25-4 ]

1-Boc-4-(3-Formylphenyl)piperazine

Similarity: 0.92

Chemical Structure| 350684-49-0

[ 350684-49-0 ]

tert-Butyl 4-(4-aminobenzoyl)piperazine-1-carboxylate

Similarity: 0.88

Chemical Structure| 927676-52-6

[ 927676-52-6 ]

tert-Butyl 4-(4-methylpiperazin-1-yl)benzylcarbamate

Similarity: 0.88

Chemical Structure| 162046-66-4

[ 162046-66-4 ]

4-(4-(tert-Butoxycarbonyl)piperazin-1-yl)benzoic acid

Similarity: 0.86